NCT06923696 is a NA clinical trial of Diet therapy in IBS - Irritable Bowel Syndrome, sponsored by Nuh Naci Yazgan University.

Who is sponsoring NCT06923696?

NCT06923696 is sponsored by Nuh Naci Yazgan University.

What drugs are being tested in NCT06923696?

Interventions in NCT06923696: Diet therapy.

What condition does NCT06923696 study?

NCT06923696 studies IBS - Irritable Bowel Syndrome, Diet, Healthy, Elimination Disorder With Fecal Symptoms.

Is NCT06923696 still recruiting?

NCT06923696 is currently completed. Last updated 11 April 2025.

Last reviewed 2025-04-11 · How we verify

NCT06923696

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Low FODMAP Diet and Gluten Free Diet in IBS

Completed NA Last updated 11 April 2025

What this trial tests

NA trial testing Diet therapy in IBS - Irritable Bowel Syndrome in 75 participants. Completed in 9 September 2024.

Timeline

27 July 2023

Primary endpoint
25 August 2024

9 September 2024

Quick facts

Lead sponsor	Nuh Naci Yazgan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	75
Start date	27 July 2023
Primary completion	25 August 2024
Estimated completion	9 September 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Diet therapy

Conditions studied

IBS - Irritable Bowel Syndrome — all drugs for IBS - Irritable Bowel Syndrome →
Diet, Healthy — all drugs for Diet, Healthy →
Elimination Disorder With Fecal Symptoms — all drugs for Elimination Disorder With Fecal Symptoms →

Sponsor

Nuh Naci Yazgan University

Who can join

Adults 18 to 65, any sex, with IBS - Irritable Bowel Syndrome or Diet, Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The data of the research will be collected from patients who have applied to the Gastroenterology Polyclinic of Kayseri City Hospital or have previously been diagnosed with Irritable Bowel Syndrome (IBS). The data will be collected through face-to-face interviews using a questionnaire form. Participation in the study is entirely voluntary, and participants have the right to withdraw from the research at any time if they wish. The general flowchart of the research is shown in Figure 1. Figure 1. Flowchart of the Research Patients with IBS applying to the Gastroenterology Polyclinic: According to Rome IV criteria, individuals aged between 19-64, with BMI \>18.5 and \<29.9 kg/m2, non-cancerous, not using probiotics in the last month, and not following a gluten-free diet. Interview Group 1: Low FODMAP diet Group 2: Gluten-free diet Socio-demographic characteristics, general dietary habits, level of physical activity, anthropometric measurements, body composition analysis, IBS-SSS, IBS-QOL, IBS-VAS, Bristol Stool Scale, 24-hour retrospective food consumption record, Food Frequency Questionnaire. Second Interview (after 4 weeks) Anthropometric measurements, body composition analysis, IBS-SSS, IBS-QOL, IBS-VAS, Bristol Stool Scale, 3-day retrospective food consumption record.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for IBS - Irritable Bowel Syndrome

Currently open trials in the same condition.

NCT06993272 — Relaxation Music for Chronic Pain · NA · active not recruiting
NCT06684470 — Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodul · EARLY_PHASE1 · recruiting
NCT06117865 — Digital Treatment of Irritable Bowel Syndrome (IBS) · NA · active not recruiting
NCT06215222 — Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease · recruiting
NCT05815602 — Ebastine Versus Mebeverine in IBS Patients · Phase 3 · recruiting

Other Nuh Naci Yazgan University trials

Trials by the same sponsor.

NCT07448636 — The Effect of Postpartum Mandala Coloring on Anxiety, Fatigue, Maternal Attachment and Breastfeeding Self-efficacy · NA · not yet recruiting
NCT06755853 — Scale for Evaluating Oral and Pharyngolaryngeal Symptoms After General Anesthesia · recruiting
NCT06802692 — Effects of Virtual Reality Glasses and Meditation Music on Anxiety, Pain, Vital Signs, Satisfaction and Pregnancy Outcom · NA · not yet recruiting
NCT05753527 — The Effect of Progressive Relaxation Exercises on Anxiety, Satisfaction and Stress Levels Before Simulation Education · NA · unknown
NCT06229314 — Effect of Inspiratory Muscle Training in Operated Adolescent Idiopathic Scoliosis · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06923696 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nuh Naci Yazgan University
Last refreshed: 11 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06923696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing